Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability.
Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability.
复制标题
DOI:
10.1016/j.nicl.2018.08.028
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Ducharme S
中科院分区:
文献类型:
--
作者:
McCarthy J;Collins DL;Ducharme S
Frontotemporal dementia (FTD) is difficult to diagnose, due to its heterogeneous nature and overlap in symptoms with primary psychiatric disorders. Brain MRI for atrophy is a key biomarker but lacks sensitivity in the early stage. Morphometric MRI-based measures and machine learning techniques are a promising tool to improve diagnostic accuracy. Our aim was to review the current state of the literature using morphometric MRI to classify FTD and assess its applicability for clinical practice. A search was completed using Pubmed and PsychInfo of studies which conducted a classification of subjects with FTD from non-FTD (controls or another disorder) using morphometric MRI metrics on an individual level, using single or combined approaches. 28 relevant articles were included and systematically reviewed following PRISMA guidelines. The studies were categorized based on the type of FTD subjects included and the group(s) against which they were classified. Studies varied considerably in subject selection, MRI methodology, and classification approach, and results are highly heterogeneous. Overall many studies indicate good diagnostic accuracy, with higher performance when differentiating FTD from controls (highest result was accuracy of 100%) than other dementias (highest result was AUC of 0.874). Very few machine learning algorithms have been tested in prospective replication. In conclusion, morphometric MRI with machine learning shows potential as an early diagnostic biomarker of FTD, however studies which use rigorous methodology and validate findings in an independent real-life cohort are necessary before this method can be recommended for use clinically.
登录
查看更多内容
影响因子:
2.1
作者:
Chow, Tiffany W.;Binns, Malcolm A.;Black, Sandra
通讯作者:
Black, Sandra
DOI:
10.1016/j.nicl.2017.02.003
发表时间:
2017
期刊:
NeuroImage. Clinical
影响因子:
--
作者:
Bisenius S;Mueller K;Diehl-Schmid J;Fassbender K;Grimmer T;Jessen F;Kassubek J;Kornhuber J;Landwehrmeyer B;Ludolph A;Schneider A;Anderl-Straub S;Stuke K;Danek A;Otto M;Schroeter ML;FTLDc study group
通讯作者:
FTLDc study group
影响因子:
3.7
作者:
Frings L;Yew B;Flanagan E;Lam BY;Hüll M;Huppertz HJ;Hodges JR;Hornberger M
通讯作者:
Hornberger M
DOI:
10.1016/j.nicl.2017.05.018
发表时间:
2017
期刊:
NeuroImage. Clinical
影响因子:
--
作者:
Canu E;Agosta F;Mandic-Stojmenovic G;Stojković T;Stefanova E;Inuggi A;Imperiale F;Copetti M;Kostic VS;Filippi M
通讯作者:
Filippi M
影响因子:
17.7
作者:
Ducharme, Simon;Price, Bruce H.;Dickerson, Bradford C.
通讯作者:
Dickerson, Bradford C.